CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer
Author:
Funder
Norwegian Cancer Society
Stiftelsen Kristian Gerhard Jebsen
Research Council of Norway
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/5/1227/25083283/mdy085.pdf
Reference31 articles.
1. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report;Moertel;Ann Intern Med,1995
2. Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology;Sepulveda;J Mol Diagn,2017
3. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data;Guastadisegni;Eur J Cancer,2010
4. Association of DNA mismatch repair and mutations in BRAF and KRAS with survival after recurrence in stage III colon cancers: a secondary analysis of 2 randomized clinical trials;Sinicrope;JAMA Oncol,2017
5. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers;Samowitz;Cancer Res,2005
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Relationship Between Serum and Tissue Levels of IL-13 and TYK2 in Colorectal Cancer Patients;Immunological Investigations;2024-09-09
2. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration;Cellular Oncology;2024-02-26
3. Using tumor habitat-derived radiomic analysis during pretreatment 18F-FDG PET for predicting KRAS/NRAS/BRAF mutations in colorectal cancer;Cancer Imaging;2024-02-12
4. The relationship of KRAS expression with KRAS status, prognosis, and tumor-infiltrated T lymphocytes in colorectal cancer;Therapeutic Advances in Gastroenterology;2024-01
5. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas;JCI Insight;2023-10-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3